Blau Farmacêutica S.A. (BVMF:BLAU3)

Market Cap	2.27B +2.0%
Revenue (ttm)	1.77B +4.9%
Net Income	324.56M +69.2%
EPS	1.40 +72.6%
Shares Out	230.99M
PE Ratio	7.01
Forward PE	7.65
Dividend	0.36 (3.61%)
Ex-Dividend Date	Dec 19, 2025

Volume	1,102,600
Average Volume	832,770
Open	10.19
Previous Close	10.30
Day's Range	9.55 - 10.20
52-Week Range	8.72 - 11.51
Beta	0.36
RSI	48.35
Earnings Date	Mar 18, 2026

About Blau Farmacêutica

Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceuticals, oncologicals, hospital products, antivirals and antiretrovirals, biológicos, acid pump inhibitor, hemoderivatives, antithrombotic, and thrombolytics...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 1,900
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BLAU3

Financial Performance

In 2024, Blau Farmacêutica's revenue was 1.75 billion, an increase of 27.81% compared to the previous year's 1.37 billion. Earnings were 217.21 million, a decrease of -13.05%.